Milestone Scientific Corporation (MLSS): רווח למניה בשנים עשר החודשים האחרונים

Adherence to electronics recycling standards ensures the assembly purity of Milestone Scientific (MLSS). The TTM EPS history demonstrates this progress, where -0.05 serves as the final level marker. Success is based on the monopolization of painless injections for patient comfort, despite liquidity challenges and slow physician adoption of the technology, which currently impacts margins.

Milestone Scientific (MLSS) is implementing innovative DPS anesthesia, overcoming the conservatism of the medical market. The EPS TTM metric measures the earnings per share distributed over a trailing twelve-month period. It allows for an assessment of real business efficiency by eliminating quarterly gaps. Investors track trend deviations to identify capital risks. By analyzing the dynamics of the net income per share over 12 months, one can evaluate the pace of patent commercialization.